News
SLS ▼ -2.0% - SELLAS Life Sciences Group, Inc.
SLS ▼ -2.0% - SELLAS Life Sciences Group, Inc.
$SLS - SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer
25-SEP-2026 01:00 PM ET
Share this post
More filings for $SLS
SLS ▲ +1.4% - SELLAS Life Sciences Group, Inc.Sep 2, 2026SLS ▼ -1.2% - SELLAS Life Sciences Group, Inc.Aug 31, 2026SLS - SELLAS Life Sciences Group, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026$SLS SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 31, 2026
View full $SLS filing history →💬 Comments
Loading comments…
Leave a comment